Goldman Sachs Maintains Buy on Teradyne, Raises Price Target to $350

Benzinga Newsdesk www.benzinga.com Positive 66.5%

Neg 0% Neu 0% Pos 66.5%

Goldman Sachs analyst James Schneider maintains Teradyne (NASDAQ:TER) with a Buy and raises the price target from $300 to $350.